CYPS — Cyclo3pss Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Cyclo3pss, fiscal year end - February 28th, USD millions except per share, conversion factor applied.

	1998 February 28th	1999 February 28th	2000 February 29th	R2001 February 28th	2002 February 28th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10KSB	10KSB	10KSB	10KSB	10KSB
Standards:	—	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1.21	0.832	0.751	0.188	0.367
Cost of Revenue
Gross Profit	0.111	0.216	0.317	-0.011	0.135
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	4.07	3.61	1.69	1.25	1.32
Operating Profit	-2.87	-2.78	-0.943	-1.07	-0.956
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-2.93	-2.78	-1.96	-1.16	-1.08
Provision for Income Taxes
Net Income After Taxes	-2.93	-2.78	-1.96	-1.16	-1.08
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-2.93	-2.78	-1.96	-1.12	-0.849
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-3.08	-3.23	-2.19	-1.13	-0.849
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.223	-0.16	-0.112	-0.041	-0.03
Dividends per Share